Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02984163 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study

Study acronym: ACE
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Jun 30, 2026 to Jun 30, 2027
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
  2. Study completion date: Jun 30, 2025 to Jun 30, 2026v12
  3. Study completion date: Jan 30, 2025 to Jun 30, 2025v11
  4. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 2500 to confirmed 2570
    • Study completion date: Dec 30, 2024 to Jan 30, 2025
    • Site details revised at 2 of 2 sites
    v10
  5. Primary completion date: Mar 30, 2024 to Sep 30, 2024
    • Study completion date: Jun 30, 2024 to Dec 30, 2024
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary completion date: Jun 30, 2023 to Mar 30, 2024
    • Study completion date: Jun 30, 2023 to Jun 30, 2024
    v8
  2. Primary completion date: Mar 31, 2022 to Jun 30, 2023
    • Study completion date: Dec 31, 2022 to Jun 30, 2023
    v7
  3. Primary completion date: Mar 31, 2021 to Mar 31, 2022
    • Study completion date: Dec 31, 2021 to Dec 31, 2022
    v6
  4. Study description expanded, about 19 wordsv5
  5. Re-verified, no change to tracked fieldsv4
  6. Enrollment target: 1000 to 2500
    • Study description revised
    v3
  7. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Mar 2021 to Mar 31, 2021
    • Study completion date: Dec 2021 to Dec 31, 2021
    • Start date: Jan 2017 to Jan 9, 2017
    • Site details revised at 2 of 2 sites
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary purpose of this proposed 5-year hybrid effectiveness and implementation study is to evaluate the relative benefit from, and implementation of an Alberta wide clinic-to-community-based cancer and exercise model of care - the Alberta Cancer Exercise (ACE) Program. The investigators hypothesize that the strategy will improve the physical well-being and QoL of survivors (on and off cancer treatment) while preventing the development of secondary cancers.
Trial Details
NCT Number NCT02984163
Lead Sponsor University of Alberta
Collaborators: University of Calgary, Alberta Health services, Cross Cancer Institute, Tom Baker Cancer Centre
Conditions
(from sponsor)		 Neoplasms
Related terms Motor Activity, Neoplasms
Enrollment 2,570 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov